Papers

Research literature with structured metadata.

Trials

Registered studies by status, phase, and compound.

Topics

Indications and themes psychedelics are researched for.

Compounds

Evidence across molecules with rich data.

Countries

Regulation, access, and research activity by region.

Stakeholders

Organizations shaping the space across research, policy, and funding.

People

Investigators, clinicians, and authors with mapped output.

Courses

Training programs and certifications across modalities.

Events

Conferences, workshops, and convenings by date and focus.

Results

Compare outcome data across trials and publications.

Research Snapshot

One-page overview of trials, participants, papers, and research networks.

Clinical Guidelines

Trial-anchored manuals and protocol guidance with competency mapping.

Research recaps

Monthly evidence summaries with key takeaways.

Map of research

Landscape view of trials, compounds, and outcomes.

Newsletter

Weekly or daily updates on trials, publications, analysis, and more.

Research Groups

Worldwide map of psychedelic research centres by region.

Road to Access

Science, regulation, and economics on the path to patient access.

Research Network

Interactive co-authorship map of psychedelic researchers.

Top papers

Find needles in the haystack of psychedelic research per topic.

AskBeta
Pricing

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.

Home/Research/5-MeO-DMT/Set & Setting

5-MeO-DMT for Set & Setting

1 paper and 0 clinical trials exploring 5-meo-dmt as a treatment for set & setting.

CompoundTryptamine

5-MeO-DMT

A potent tryptamine psychedelic known for profound mystical experiences, currently under clinical investigation for TRD and anxiety.

Full 5-MeO-DMT profile
IndicationApproximately 264 million individuals worldwide suffer from depression, with many seeking innovative treatment options such as psychedelic-assisted therapy.

Set & Setting

The concept of 'set and setting' is critical in psychedelic research, influencing therapeutic outcomes in clinical environments. Creating optimal conditions is essential for maximising the efficacy and safety of psychedelic-assisted therapies, particularly in the context of mental health disorders.

Full Set & Setting profile

Academic Research

1 paper
Open Accessindividual

Language Models Learn Sentiment and Substance from 11,000 Psychoactive Experiences

Using BERT on 11,816 public drug testimonials, the authors extracted 28-dimensional sentiment and biochemical/demographic signals and—via canonical correlation analysis—linked testimonial language to receptor‑binding profiles, revealing 11 latent receptor–experience factors that were mapped onto a 3D cortical atlas. The models converged on a lucid–mundane experiential axis, linked specific drugs (e.g. MDMA with “Love”, DMT/5‑MeO‑DMT with “Mystical Experiences”) and propose that real‑time biofeedback could help steer therapeutic psychedelic sessions.

Published
June 6, 2022
Journal
Biorxiv
Authors
Friedman, S. F., Ballentine, G.

Clinical Trials

0 trials

No clinical trials have been tagged with both 5-MeO-DMT and Set & Setting yet.

Trials are continuously being added as new studies are registered.

Explore further

Search all 5-MeO-DMT papers Search all Set & Setting trials Full 5-MeO-DMT profile Full Set & Setting profile